The novel coronavirus (SARS-CoV-2) and its many mutations, such as the Omicron variant, is currently spreading rapidly throughout the globe and is exerting a detrimental effect on the greater populace and their general quality of life.

To combat the virus and aid in vaccine development, contact tracing, and virus research, the whole genome sequence analysis of SARS-CoV-2 has become necessary.

Celemics has developed reagents and bioinformatics software specifically optimized to amplify the SARS-CoV-2 whole genome sequence, resulting in the provision of high-quality analysis results of the viral whole genome sequence within 24 hours.

Celemics has developed reagents and bioinformatics software specifically optimized to the
amplification of the SARS-CoV-2 whole genome sequence, resulting in the provision of
high-quality analysis results of the viral whole genome sequence within 24 hours.

In most cases, RNA of the host cell is separated and purified along with viral RNA during extraction. This leads to an excessive amount of data required to perform typical total RNA-seq compared to the entire viral genome, resulted in low-quality data and high costs. Celemics solves this issue by developing extremely uniform amplification technology and bioinformatics software, which in turn provides quality data by efficiently eliminating any gaps generated from bias in the RT-PCR step.

By using Celemics’ proprietary reagents and bioinformatics SW technology,
full-length sequencing of novel coronaviruses is possible within up to 24 hours.